Adaptive trials allow for modifications to be made during the trial without requiring additional approvals. According to the ...

Currently available PCSK9-targeting therapies are Amgen's Repatha (evolocumab) and Sanofi/Regeneron's Praluent (alirocumab), ...

Health and Human Services (HHS) Secretary Robert F Kennedy Jr has removed all 17 members of the CDC's Advisory Committee on ...

Asked where AI is having the biggest impact in digital engagement, around half (49%) of respondents said it was in data ...

The green light in the US is the first worldwide for Enflonsia ( clesrovimab) and makes the long-acting antibody the first ...

NewAmsterdam Pharma has said that an oral drug it is developing to lower cholesterol has shown preliminary efficacy as a ...

AbbVie presented new data from its novel antibody-drug conjugates (ADCs) at ASCO 2025, including telisotuzumab adizutecan ...

Novo Nordisk's GLP-1 agonist semaglutide, used to treat diabetes and obesity, may cause a serious eye condition that can lead ...

Going into 2025, we expect pharma brands and their advertising partners to use past learnings – and, more importantly – ...

Changing a cultural undertow is one of the hardest leadership challenges in any industry, and perhaps even more so in the ...

The tantalising development has been reported by researchers at the Peter Doherty Institute for Infection and Immunity in ...

UK start-up George Medicines has brought its triple therapy for high blood pressure over the finish line, with an FDA ...